PATENT CLAIM ANALYSIS

Application Number: 16077889
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "256000"]

Abstract:
An object of the present invention is to provide a compound with an excellent JAK1 inhibitory activity. The compound of the invention has JAK1 inhibitory activity, and thus, immunosuppressive effect, anti-inflammatory effect, anti-proliferative effect and so on, and is useful in the treatment of the diseases, for example, rheumatoid arthritis, inflammatory bowel disease, psoriasis, vasculitis, bronchial asthma, chronic obstructive pulmonary disease, eosinophilic sinusitis and nasal polyp.

Claim (Index 16):
A pharmaceutical composition comprising the crystal according to  claim 2  as an active ingredient.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.58824
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15505767', '15830181', '15580450', '14160699', '14734012']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7535698062051281
- 35 USC 102 Novelty (BERT): 0.6073485360726182
- Combined Prediction Score: 0.7389476791918772
- Mean Citation Score: 412.260262
- Max Citation Score: 647.13837
- Similarity Product: 433.94942700776704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test